CNO Financial Group, Inc. 5.125
CNO Financial Group, Inc. 5.125 CNO-PA Peers
See (CNO-PA) competitors and their performances in Stock Market.
Peer Comparison Table: Insurance - Diversified Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
---|---|---|---|---|---|---|
CNO-PA | $17.49 | +0.11% | 3.8B | N/A | N/A | +1.74% |
BRK-B | $490.37 | +0.58% | 1.1T | 13.15 | $37.29 | N/A |
BRK-A | $734,840.00 | +0.50% | 1.1T | 13.05 | $56,300.03 | N/A |
AIG-PA | $62.68 | +6.02% | 112.5B | 5.48 | $11.44 | +1.93% |
AEH | $25.67 | N/A | 52.5B | 19.37 | $1.33 | N/A |
AED | $25.52 | N/A | 52.2B | 19.26 | $1.33 | N/A |
AEB | $25.01 | -0.08% | 51.1B | 18.88 | $1.33 | N/A |
AIG | $85.45 | +0.99% | 49.2B | 20.84 | $4.10 | +1.93% |
SLF | $64.69 | +0.59% | 36.6B | 16.13 | $4.01 | +3.73% |
HIG | $125.87 | +0.51% | 35.8B | 12.74 | $9.88 | +1.61% |
Stock Comparison
CNO-PA vs BRK-B Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, BRK-B has a market cap of 1.1T. Regarding current trading prices, CNO-PA is priced at $17.49, while BRK-B trades at $490.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas BRK-B's P/E ratio is 13.15. In terms of profitability, CNO-PA's ROE is +0.12%, compared to BRK-B's ROE of +0.13%. Regarding short-term risk, CNO-PA is less volatile compared to BRK-B. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs BRK-A Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, BRK-A has a market cap of 1.1T. Regarding current trading prices, CNO-PA is priced at $17.49, while BRK-A trades at $734,840.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas BRK-A's P/E ratio is 13.05. In terms of profitability, CNO-PA's ROE is +0.12%, compared to BRK-A's ROE of +0.13%. Regarding short-term risk, CNO-PA is less volatile compared to BRK-A. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs AIG-PA Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, AIG-PA has a market cap of 112.5B. Regarding current trading prices, CNO-PA is priced at $17.49, while AIG-PA trades at $62.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AIG-PA's P/E ratio is 5.48. In terms of profitability, CNO-PA's ROE is +0.12%, compared to AIG-PA's ROE of -0.04%. Regarding short-term risk, CNO-PA is less volatile compared to AIG-PA. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs AEH Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, AEH has a market cap of 52.5B. Regarding current trading prices, CNO-PA is priced at $17.49, while AEH trades at $25.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AEH's P/E ratio is 19.37. In terms of profitability, CNO-PA's ROE is +0.12%, compared to AEH's ROE of N/A. Regarding short-term risk, CNO-PA is less volatile compared to AEH. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs AED Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, AED has a market cap of 52.2B. Regarding current trading prices, CNO-PA is priced at $17.49, while AED trades at $25.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AED's P/E ratio is 19.26. In terms of profitability, CNO-PA's ROE is +0.12%, compared to AED's ROE of N/A. Regarding short-term risk, CNO-PA is less volatile compared to AED. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs AEB Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, AEB has a market cap of 51.1B. Regarding current trading prices, CNO-PA is priced at $17.49, while AEB trades at $25.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AEB's P/E ratio is 18.88. In terms of profitability, CNO-PA's ROE is +0.12%, compared to AEB's ROE of N/A. Regarding short-term risk, CNO-PA is less volatile compared to AEB. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs AIG Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, AIG has a market cap of 49.2B. Regarding current trading prices, CNO-PA is priced at $17.49, while AIG trades at $85.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AIG's P/E ratio is 20.84. In terms of profitability, CNO-PA's ROE is +0.12%, compared to AIG's ROE of -0.04%. Regarding short-term risk, CNO-PA is less volatile compared to AIG. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs SLF Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, SLF has a market cap of 36.6B. Regarding current trading prices, CNO-PA is priced at $17.49, while SLF trades at $64.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas SLF's P/E ratio is 16.13. In terms of profitability, CNO-PA's ROE is +0.12%, compared to SLF's ROE of +0.13%. Regarding short-term risk, CNO-PA is less volatile compared to SLF. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs HIG Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, HIG has a market cap of 35.8B. Regarding current trading prices, CNO-PA is priced at $17.49, while HIG trades at $125.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas HIG's P/E ratio is 12.74. In terms of profitability, CNO-PA's ROE is +0.12%, compared to HIG's ROE of +0.18%. Regarding short-term risk, CNO-PA is less volatile compared to HIG. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs HIG-PG Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, HIG-PG has a market cap of 35.6B. Regarding current trading prices, CNO-PA is priced at $17.49, while HIG-PG trades at $24.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas HIG-PG's P/E ratio is 3.40. In terms of profitability, CNO-PA's ROE is +0.12%, compared to HIG-PG's ROE of +0.18%. Regarding short-term risk, CNO-PA is less volatile compared to HIG-PG. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs ACGL Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, ACGL has a market cap of 34.2B. Regarding current trading prices, CNO-PA is priced at $17.49, while ACGL trades at $91.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ACGL's P/E ratio is 9.35. In terms of profitability, CNO-PA's ROE is +0.12%, compared to ACGL's ROE of +0.18%. Regarding short-term risk, CNO-PA is less volatile compared to ACGL. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs ACGLO Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, ACGLO has a market cap of 32.8B. Regarding current trading prices, CNO-PA is priced at $17.49, while ACGLO trades at $20.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ACGLO's P/E ratio is 4.28. In terms of profitability, CNO-PA's ROE is +0.12%, compared to ACGLO's ROE of +0.18%. Regarding short-term risk, CNO-PA is less volatile compared to ACGLO. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs ATH Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, ATH has a market cap of 19.8B. Regarding current trading prices, CNO-PA is priced at $17.49, while ATH trades at $83.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ATH's P/E ratio is 4.42. In terms of profitability, CNO-PA's ROE is +0.12%, compared to ATH's ROE of +0.20%. Regarding short-term risk, CNO-PA is less volatile compared to ATH. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs PFG Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, PFG has a market cap of 17.2B. Regarding current trading prices, CNO-PA is priced at $17.49, while PFG trades at $76.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas PFG's P/E ratio is 16.42. In terms of profitability, CNO-PA's ROE is +0.12%, compared to PFG's ROE of +0.10%. Regarding short-term risk, CNO-PA is less volatile compared to PFG. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs EQH Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, EQH has a market cap of 16.1B. Regarding current trading prices, CNO-PA is priced at $17.49, while EQH trades at $53.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas EQH's P/E ratio is 14.29. In terms of profitability, CNO-PA's ROE is +0.12%, compared to EQH's ROE of +0.57%. Regarding short-term risk, CNO-PA is less volatile compared to EQH. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs ACGLP Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, ACGLP has a market cap of 15.2B. Regarding current trading prices, CNO-PA is priced at $17.49, while ACGLP trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ACGLP's P/E ratio is 5.03. In terms of profitability, CNO-PA's ROE is +0.12%, compared to ACGLP's ROE of +0.18%. Regarding short-term risk, CNO-PA is less volatile compared to ACGLP. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs BNT Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, BNT has a market cap of 14.2B. Regarding current trading prices, CNO-PA is priced at $17.49, while BNT trades at $58.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas BNT's P/E ratio is 14.42. In terms of profitability, CNO-PA's ROE is +0.12%, compared to BNT's ROE of +0.05%. Regarding short-term risk, CNO-PA is less volatile compared to BNT. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs UNMA Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, UNMA has a market cap of 13.8B. Regarding current trading prices, CNO-PA is priced at $17.49, while UNMA trades at $23.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas UNMA's P/E ratio is 4.98. In terms of profitability, CNO-PA's ROE is +0.12%, compared to UNMA's ROE of +0.15%. Regarding short-term risk, CNO-PA is less volatile compared to UNMA. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs AEG Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, AEG has a market cap of 11.3B. Regarding current trading prices, CNO-PA is priced at $17.49, while AEG trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AEG's P/E ratio is 16.31. In terms of profitability, CNO-PA's ROE is +0.12%, compared to AEG's ROE of +0.08%. Regarding short-term risk, CNO-PA is less volatile compared to AEG. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs AIZN Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, AIZN has a market cap of 10.1B. Regarding current trading prices, CNO-PA is priced at $17.49, while AIZN trades at $19.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas AIZN's P/E ratio is N/A. In terms of profitability, CNO-PA's ROE is +0.12%, compared to AIZN's ROE of +0.13%. Regarding short-term risk, CNO-PA is less volatile compared to AIZN. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs ORI Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, ORI has a market cap of 9.2B. Regarding current trading prices, CNO-PA is priced at $17.49, while ORI trades at $37.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ORI's P/E ratio is 12.22. In terms of profitability, CNO-PA's ROE is +0.12%, compared to ORI's ROE of +0.13%. Regarding short-term risk, CNO-PA is less volatile compared to ORI. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs ACGLN Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, ACGLN has a market cap of 6.2B. Regarding current trading prices, CNO-PA is priced at $17.49, while ACGLN trades at $16.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ACGLN's P/E ratio is 3.53. In terms of profitability, CNO-PA's ROE is +0.12%, compared to ACGLN's ROE of +0.18%. Regarding short-term risk, CNO-PA is less volatile compared to ACGLN. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs EQH-PA Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, EQH-PA has a market cap of 6.1B. Regarding current trading prices, CNO-PA is priced at $17.49, while EQH-PA trades at $20.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas EQH-PA's P/E ratio is 5.30. In terms of profitability, CNO-PA's ROE is +0.12%, compared to EQH-PA's ROE of +0.57%. Regarding short-term risk, CNO-PA is less volatile compared to EQH-PA. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs ATH-PE Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, ATH-PE has a market cap of 5.2B. Regarding current trading prices, CNO-PA is priced at $17.49, while ATH-PE trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ATH-PE's P/E ratio is N/A. In terms of profitability, CNO-PA's ROE is +0.12%, compared to ATH-PE's ROE of +0.20%. Regarding short-term risk, CNO-PA is less volatile compared to ATH-PE. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs ATH-PC Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, ATH-PC has a market cap of 5.1B. Regarding current trading prices, CNO-PA is priced at $17.49, while ATH-PC trades at $24.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ATH-PC's P/E ratio is 3.14. In terms of profitability, CNO-PA's ROE is +0.12%, compared to ATH-PC's ROE of +0.20%. Regarding short-term risk, CNO-PA is less volatile compared to ATH-PC. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs ESGRO Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, ESGRO has a market cap of 5.1B. Regarding current trading prices, CNO-PA is priced at $17.49, while ESGRO trades at $20.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ESGRO's P/E ratio is -13.50. In terms of profitability, CNO-PA's ROE is +0.12%, compared to ESGRO's ROE of +0.08%. Regarding short-term risk, CNO-PA is less volatile compared to ESGRO. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs ESGRP Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, ESGRP has a market cap of 5B. Regarding current trading prices, CNO-PA is priced at $17.49, while ESGRP trades at $20.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ESGRP's P/E ratio is -13.72. In terms of profitability, CNO-PA's ROE is +0.12%, compared to ESGRP's ROE of +0.08%. Regarding short-term risk, CNO-PA is less volatile compared to ESGRP. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs ESGR Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, ESGR has a market cap of 5B. Regarding current trading prices, CNO-PA is priced at $17.49, while ESGR trades at $336.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ESGR's P/E ratio is 10.78. In terms of profitability, CNO-PA's ROE is +0.12%, compared to ESGR's ROE of +0.08%. Regarding short-term risk, CNO-PA is less volatile compared to ESGR. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs EQH-PC Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, EQH-PC has a market cap of 5B. Regarding current trading prices, CNO-PA is priced at $17.49, while EQH-PC trades at $16.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas EQH-PC's P/E ratio is 4.30. In terms of profitability, CNO-PA's ROE is +0.12%, compared to EQH-PC's ROE of +0.57%. Regarding short-term risk, CNO-PA is less volatile compared to EQH-PC. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs ATH-PA Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, ATH-PA has a market cap of 4.9B. Regarding current trading prices, CNO-PA is priced at $17.49, while ATH-PA trades at $24.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ATH-PA's P/E ratio is 3.03. In terms of profitability, CNO-PA's ROE is +0.12%, compared to ATH-PA's ROE of +0.20%. Regarding short-term risk, CNO-PA is less volatile compared to ATH-PA. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs ATH-PB Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, ATH-PB has a market cap of 3.9B. Regarding current trading prices, CNO-PA is priced at $17.49, while ATH-PB trades at $19.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ATH-PB's P/E ratio is 2.42. In terms of profitability, CNO-PA's ROE is +0.12%, compared to ATH-PB's ROE of +0.20%. Regarding short-term risk, CNO-PA is less volatile compared to ATH-PB. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs GSHD Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, GSHD has a market cap of 3.8B. Regarding current trading prices, CNO-PA is priced at $17.49, while GSHD trades at $101.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas GSHD's P/E ratio is 85.95. In terms of profitability, CNO-PA's ROE is +0.12%, compared to GSHD's ROE of +2.32%. Regarding short-term risk, CNO-PA is less volatile compared to GSHD. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs ATH-PD Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, ATH-PD has a market cap of 3.4B. Regarding current trading prices, CNO-PA is priced at $17.49, while ATH-PD trades at $16.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ATH-PD's P/E ratio is 2.09. In terms of profitability, CNO-PA's ROE is +0.12%, compared to ATH-PD's ROE of +0.20%. Regarding short-term risk, CNO-PA is less volatile compared to ATH-PD. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs FIHL Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, FIHL has a market cap of 1.8B. Regarding current trading prices, CNO-PA is priced at $17.49, while FIHL trades at $16.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas FIHL's P/E ratio is -185.67. In terms of profitability, CNO-PA's ROE is +0.12%, compared to FIHL's ROE of +0.04%. Regarding short-term risk, CNO-PA is less volatile compared to FIHL. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs RZC Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, RZC has a market cap of 1.7B. Regarding current trading prices, CNO-PA is priced at $17.49, while RZC trades at $25.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas RZC's P/E ratio is N/A. In terms of profitability, CNO-PA's ROE is +0.12%, compared to RZC's ROE of +0.06%. Regarding short-term risk, CNO-PA is less volatile compared to RZC. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs IGIC Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, IGIC has a market cap of 1.1B. Regarding current trading prices, CNO-PA is priced at $17.49, while IGIC trades at $23.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas IGIC's P/E ratio is 8.49. In terms of profitability, CNO-PA's ROE is +0.12%, compared to IGIC's ROE of +0.20%. Regarding short-term risk, CNO-PA is less volatile compared to IGIC. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs YB Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, YB has a market cap of 894.8M. Regarding current trading prices, CNO-PA is priced at $17.49, while YB trades at $19.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas YB's P/E ratio is 9.41. In terms of profitability, CNO-PA's ROE is +0.12%, compared to YB's ROE of -0.32%. Regarding short-term risk, CNO-PA is less volatile compared to YB. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs ARGD Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, ARGD has a market cap of 700.7M. Regarding current trading prices, CNO-PA is priced at $17.49, while ARGD trades at $20.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ARGD's P/E ratio is N/A. In terms of profitability, CNO-PA's ROE is +0.12%, compared to ARGD's ROE of -0.10%. Regarding short-term risk, CNO-PA is less volatile compared to ARGD. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs WDH Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, WDH has a market cap of 48.3M. Regarding current trading prices, CNO-PA is priced at $17.49, while WDH trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas WDH's P/E ratio is 8.90. In terms of profitability, CNO-PA's ROE is +0.12%, compared to WDH's ROE of +0.08%. Regarding short-term risk, CNO-PA is less volatile compared to WDH. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs FGF Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, FGF has a market cap of 23.5M. Regarding current trading prices, CNO-PA is priced at $17.49, while FGF trades at $18.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas FGF's P/E ratio is -0.82. In terms of profitability, CNO-PA's ROE is +0.12%, compared to FGF's ROE of -0.09%. Regarding short-term risk, CNO-PA is less volatile compared to FGF. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs FGFPP Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, FGFPP has a market cap of 20.9M. Regarding current trading prices, CNO-PA is priced at $17.49, while FGFPP trades at $16.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas FGFPP's P/E ratio is -6.47. In terms of profitability, CNO-PA's ROE is +0.12%, compared to FGFPP's ROE of -0.09%. Regarding short-term risk, CNO-PA is less volatile compared to FGFPP. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs IGICW Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, IGICW has a market cap of 0. Regarding current trading prices, CNO-PA is priced at $17.49, while IGICW trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas IGICW's P/E ratio is N/A. In terms of profitability, CNO-PA's ROE is +0.12%, compared to IGICW's ROE of +0.20%. Regarding short-term risk, CNO-PA is less volatile compared to IGICW. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs ANAT Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, ANAT has a market cap of 0. Regarding current trading prices, CNO-PA is priced at $17.49, while ANAT trades at $188.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas ANAT's P/E ratio is 6.73. In terms of profitability, CNO-PA's ROE is +0.12%, compared to ANAT's ROE of +0.10%. Regarding short-term risk, CNO-PA is less volatile compared to ANAT. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.
CNO-PA vs WTREP Comparison
CNO-PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNO-PA stands at 3.8B. In comparison, WTREP has a market cap of 0. Regarding current trading prices, CNO-PA is priced at $17.49, while WTREP trades at $25.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNO-PA currently has a P/E ratio of N/A, whereas WTREP's P/E ratio is 1.35. In terms of profitability, CNO-PA's ROE is +0.12%, compared to WTREP's ROE of +0.00%. Regarding short-term risk, CNO-PA is less volatile compared to WTREP. This indicates potentially lower risk in terms of short-term price fluctuations for CNO-PA.